What Is the Protocol for Ristova? Understanding Rituximab Infusions
•
5 min read
Ristova, a brand name for the monoclonal antibody rituximab, targets B-cells to treat a range of conditions from non-Hodgkin's lymphoma to rheumatoid arthritis. Adhering to the specific protocol for Ristova is critical for maximizing its therapeutic benefits while mitigating the risk of serious side effects, such as potentially severe infusion-related reactions.
